Search research articles
Contact Us
Filters
Showing results (11-20 of 20) with videos related to
Page
of 2
Sort By:
You have reached the last page of results.
This site can display upto 20 results.
International Journal of Cancer
|
May 13, 2003
Mutational events in LMP1 gene of Epstein-Barr virus in salivary gland lymphoepithelial carcinomas
Kai Yu Jen, Jun Cheng, Jian Li, et al.
Journal of Immunology (Baltimore, Md. : 1950)
|
September 6, 2007
CD45RB ligation inhibits allergic pulmonary inflammation by inducing CTLA4 transcription
Kai Yu Jen, Monica Campo, Hongzhen He, et al.
Journal of Immunology (Baltimore, Md. : 1950)
|
April 14, 2010
T cell pathways involving CTLA4 contribute to a model of acute lung injury
Takeshi Nakajima, Carlos Jose Suarez, Ko-Wei Lin, et al.
Respiratory Research
|
January 16, 2008
(R)-albuterol decreases immune responses: role of activated T cells
Marcela A Ferrada, Erin L Gordon, Kai Yu Jen, et al.
Virus Genes
|
March 4, 2005
Nucleotide sequences and functions of the Epstein-Barr virus latent membrane protein 1 genes isolated from salivary gland lymphoepithelial carcinomas
Kai Yu Jen, Masaya Higuchi, Jun Cheng, et al.
The AAPS Journal
|
July 29, 2021
An Integrated Analysis of Dostarlimab Immunogenicity
Sharon Lu, Ronald R Bowsher, Amanda Clancy, et al.
Molecular Cancer Therapeutics
|
December 5, 2024
First Results of Migoprotafib, a Potent and Highly Selective Src Homology-2 Domain-Containing Phosphatase 2 Inhibitor in Patients with Advanced Solid Tumors
Melissa L Johnson, Beni B Wolf, Judy S Wang, et al.
Arkhiv Patologii
|
September 11, 2004
Epstein-Barr virus infected lymphoepithelial carcinomas of the salivary gland in the Russia-Asia area: a clinicopathologic study of 160 cases
Takashi Saku, Jun Cheng, Kai Yu Jen, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
July 24, 2021
Niraparib for Advanced Breast Cancer with Germline <i>BRCA1</i> and <i>BRCA2</i> Mutations: the EORTC 1307-BCG/BIG5-13/TESARO PR-30-50-10-C BRAVO Study
Nicholas C Turner, Judith Balmaña, Coralie Poncet, et al.
Cancer Discovery
|
June 4, 2023
RLY-4008, the First Highly Selective FGFR2 Inhibitor with Activity across FGFR2 Alterations and Resistance Mutations
Vivek Subbiah, Vaibhav Sahai, Dejan Maglic, et al.
Page
of 2
Search research articles
Search
Showing results (11-20 of 20) with videos related to
Sort By:
Page
of 2
You have reached the last page of results.
This site can display upto 20 results.
International Journal of Cancer
|
May 13, 2003
Mutational events in LMP1 gene of Epstein-Barr virus in salivary gland lymphoepithelial carcinomas
Kai Yu Jen, Jun Cheng, Jian Li, et al.
Journal of Immunology (Baltimore, Md. : 1950)
|
September 6, 2007
CD45RB ligation inhibits allergic pulmonary inflammation by inducing CTLA4 transcription
Kai Yu Jen, Monica Campo, Hongzhen He, et al.
Journal of Immunology (Baltimore, Md. : 1950)
|
April 14, 2010
T cell pathways involving CTLA4 contribute to a model of acute lung injury
Takeshi Nakajima, Carlos Jose Suarez, Ko-Wei Lin, et al.
Respiratory Research
|
January 16, 2008
(R)-albuterol decreases immune responses: role of activated T cells
Marcela A Ferrada, Erin L Gordon, Kai Yu Jen, et al.
Virus Genes
|
March 4, 2005
Nucleotide sequences and functions of the Epstein-Barr virus latent membrane protein 1 genes isolated from salivary gland lymphoepithelial carcinomas
Kai Yu Jen, Masaya Higuchi, Jun Cheng, et al.
The AAPS Journal
|
July 29, 2021
An Integrated Analysis of Dostarlimab Immunogenicity
Sharon Lu, Ronald R Bowsher, Amanda Clancy, et al.
Molecular Cancer Therapeutics
|
December 5, 2024
First Results of Migoprotafib, a Potent and Highly Selective Src Homology-2 Domain-Containing Phosphatase 2 Inhibitor in Patients with Advanced Solid Tumors
Melissa L Johnson, Beni B Wolf, Judy S Wang, et al.
Arkhiv Patologii
|
September 11, 2004
Epstein-Barr virus infected lymphoepithelial carcinomas of the salivary gland in the Russia-Asia area: a clinicopathologic study of 160 cases
Takashi Saku, Jun Cheng, Kai Yu Jen, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
July 24, 2021
Niraparib for Advanced Breast Cancer with Germline <i>BRCA1</i> and <i>BRCA2</i> Mutations: the EORTC 1307-BCG/BIG5-13/TESARO PR-30-50-10-C BRAVO Study
Nicholas C Turner, Judith Balmaña, Coralie Poncet, et al.
Cancer Discovery
|
June 4, 2023
RLY-4008, the First Highly Selective FGFR2 Inhibitor with Activity across FGFR2 Alterations and Resistance Mutations
Vivek Subbiah, Vaibhav Sahai, Dejan Maglic, et al.
Page
of 2